Missouri Attorney General Catherine Hanaway has ordered Eli Lilly to stop requiring hospitals to hand over detailed claims data before they can buy its medicines at federally discounted prices. In an Oct. 26 cease-and-desist letter, Hanaway gave the drugmaker until Nov. 26 to end the policy, STAT reported.
The letter also demands that Lilly stop using claims data already collected under the policy. Hanaway's office warned that failure to comply could lead to enforcement under the Missouri Merchandising Practices Act, the state's main consumer protection law, according to Becker's Hospital Review.